Aptus Capital Advisors, LLC Ark Genomic Revolution ETF (De Transaction History
Aptus Capital Advisors, LLC
- $6.27 Billion
- Q3 2024
A detailed history of Aptus Capital Advisors, LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 520 shares of ARKG stock, worth $12,313. This represents 0.0% of its overall portfolio holdings.
Number of Shares
520
Previous 520
-0.0%
Holding current value
$12,313
Previous $12,000
8.33%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ARKG
# of Institutions
287Shares Held
24.5MCall Options Held
3.02MPut Options Held
2.65M-
Jpmorgan Chase & CO New York, NY2.96MShares$70 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC2.9MShares$68.7 Million0.01% of portfolio
-
Main Management ETF Advisors, LLC San Francisco, CA2.43MShares$57.5 Million2.95% of portfolio
-
Goldman Sachs Group Inc New York, NY1.81MShares$42.9 Million0.01% of portfolio
-
Citigroup Inc1.68MShares$39.8 Million0.03% of portfolio